Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma

European Journal of Surgical Oncology

Volumn 35, Issue 6, 2009, Pages 568-572

  Duprat, J P ^a   Domingues, A L ^a   Coelho, E G ^b   Leal, R M L V ^b   Nishinari, K ^a   Neves, R I ^c  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Oncologic Surgery of the Hospital do Câncer A C Camargo   (Brazil)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Carcinoma; Literature review; Merkel cell; Regional perfusion cancer chemotherapy; Tumor necrosis factor alpha

Indexed keywords

CHLORMETHINE; DACTINOMYCIN; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; INOPERABLE CANCER; MALE; MERKEL CELL TUMOR; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, MERKEL CELL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FATAL OUTCOME; FEMALE; GROIN; HUMANS; HYPERTHERMIA, INDUCED; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELPHALAN; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349189134     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.10.002     Document Type: Review

References (26)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 105 (1972) 107-110
2. Agelli M., and Clegg L.X. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 49 5 (2003) 832-841
3. Hodgson N.C. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 89 1 (2005) 1-4
4. Gupta S.G., Wang L.C., Peñas P.F., Gellenthin M., Lee S.J., and Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 142 (2006) 685-690
5. Eng T.Y., Boersma M.G., Fuller C.D., et al. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol 30 6 (2007) 624-636
6. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 5866 (2008) 1096-1100
7. Ratner D., Nelson B.R., Brown M.D., and Johnson T.M. Merkel cell carcinoma. J Am Acad Dermatol 29 (1993) 143-156
8. Haag M.L., Glass L.F., and Fenske N.A. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 21 (1995) 669-683
9. Hitchcock C.L., Bland K.I., Laney III R.G., Franzini D., Harris B., and Copeland III E.M. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis and treatment. Ann Surg 207 (1988) 201-207
10. Cotlar A.M., Gates J.O., and Gibbs F.A. Merkel cell carcinoma: combined surgery and radiation therapy. Am Surg 52 (1986) 159-164
11. Yiengpruksawan A., Coit D.G., Thaler H.T., Urmacher C., and Knapper W.K. Merkel cell carcinoma: prognosis and management. Arch Surg 126 (1991) 1514-1519
12. Olieman A.F., Liénard D., Eggermont A.M., et al. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg 134 3 (1999) 303-307
13. Feun L.G., Savarj N., Legha S.S., Silva E.G., Benjamin R.S., and Burgess M.A. Chemotherapy for Metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience. Cancer 62 4 (1988) 683-685
14. Dawson R., Williams O.M., and Mansel R.E. Isolated hyperthermic limb perfusion chemotherapy in Merkel cell tumour: a case report. J R Coll Surg Edinb 41 4 (1996) 255-256
15. Lampreave J.L., Bénard F., Alavi A., Jimenez-Hoyuela J., and Fraker D. PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma. J Nucl Med 39 12 (1998) 2087-2090
16. Gupta A.S., Heinzman S., and Levine E.A. Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion. South Med J 91 3 (1998) 289-292
17. Grandpeix C., Bonvalot S., Petrow P., Fraitag S., Gounod N., and Avril M.F. Continued complete remession of Merkel cell carcinoma with in transit metastasis after treatment with isolated limb perfusion chemotherapy. Ann Dermatol Venereol 133 (2006) 700-703
18. Thompson J.F., Good P.D., and Kam P.C.A. Hyperthermic isolated limb perfusion in the treatment of melanoma: technical aspects. Reg Cancer Treat 7 (1994) 14754
19. Eggermont A.M., Schraffordt Koops H., Klausner J.M., et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 224 6 (1996) 756-765
20. Pectasides D., Pectasides M., and Economopoulus T. Merkel cell cancer of the skin. Ann Oncol 17 (2006) 1489-1495
21. Eng T.Y., Boersma M.G., Fuller C.D., Cavanaugh S.X., Valenzuela F., and Herman T.S. Treatment of merkel cell carcinoma. Am J Clin Oncol 27 5 (2004) 510-515
22. Helm K.F., Billingsley E.Y., Zangwill B.C., and Schwartz R.A. Localized limb cutaneous metastases. J Surg Oncol 67 4 (1998) 261-264
23. Lewis K.G., Weinstock M.A., Weaver A.L., and Otley C.C. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 142 (2006) 693-700
24. Mortier L., Mirabel X., Fournier C., Piette F., and Lartigau E. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 139 12 (2003) 1587-1590
25. Liénard D., Eggermont A.M., Schraffordt Koops H., et al. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res 4 Suppl. 1 (1994) 21-26
26. Cornett W.R., Mc Call L.M., Petersen R.P., et al. Randomized multicenter trial of hypertermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol 24 25 (2006) 4196-4201